?? Join us today at #SNO2024 to hear Drs. Jennifer Yu and Alireza Mohammadi discuss their findings on the safety of expedited chemoradiation post-LITT in patients with newly diagnosed glioblastoma. Rx Only. https://bit.ly/3pdAg6x
关于我们
Monteris is a private equity backed neurosurgical company focused solely on diseases of the brain. The company was founded in Winnipeg, Canada in 1999 to create neurosurgical technology that, when used by neurosurgeons, would allow them to ablate brain tumors and lesions that may be difficult to approach via traditional methods. The NeuroBlate? System is a minimally invasive robotically controlled laser thermal therapy that uses MRI-guided laser light to ablate (destroy) unwanted tissue in the brain where a lesion, or abnormal tissue, originates. Monteris has offices in Minnetonka, Minnesota, USA and Winnipeg, Manitoba, Canada.
- 网站
-
https://www.monteris.com
Monteris Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Minnetonka，MN
- 类型
- 私人持股
- 创立
- 1999
- 领域
- Neurosurgical Ablation、NeuroBlate System、MRI Guided Ablation、Laser Ablation、Neurosurgery、Neurological Surgeon和Stereotactic Laser Ablation
地点
-
主要
获取路线
131 Cheshire Lane
Suite 100
US，MN，Minnetonka，55305
Monteris Medical员工
动态
-
Stop by booth 411 at #SNO2024 to discuss the newest publication from our LAANTERN prospective multi-center study, the largest published cohort to date: LITT with the NeuroBlate System for new and recurrent meningioma. Rx Only. https://bit.ly/3pdAg6x
-
-
Did you know that over 3 million people in the U.S. are living with epilepsy, and 470,000 of them are children? We are deeply committed to supporting families impacted by drug-resistant epilepsy. Our new NB3 cooled laser probe features an ultra-small 1.6mm diameter, optimized for precise targeting in pediatric patients with difficult to access lesions in critical areas. Rx Only. https://bit.ly/3pdAg6x
-
-
Advancing Science at #SNO2024. Discover the latest evidence in laser probe technology and see NEW DATA on Expedited Chemoradiation after LITT from Dr. Alireza Mohammadi and Dr. Jennifer Yu from the Cleveland Clinic. Rx Only. https://bit.ly/3pdAg6x
-
-
November is National Epilepsy Awareness Month and EVERYONE deserves the opportunity to live seizure free. As the leader in #LITT, we are proud to be at the forefront of minimally invasive solutions for those living with drug-resistant epilepsy. Epilepsy Foundation Rx Only. https://bit.ly/3pdAg6x
-
-
We are thrilled to share that the 7,000th NeuroBlate procedure was performed this week by Dr. James Rutka and his team at The Hospital for Sick Children in Toronto! A notable milestone as the NeuroBlate System was originally developed in Canada. We look forward to continued leadership and innovation in the #LITT space! Rx Only. https://bit.ly/3pdAg6x
-
-
Your pediatric patients may benefit from #LITT. Learn more about the new NB3 1.6mm Laser Probe. Explore the extensive capabilities of this ultra-compact probe. SMALL diameter, EXPANSIVE possibilities. Rx Only. https://bit.ly/3pdAg6x
-
-
Everyone living with epilepsy deserves access to education about SUDEP (Sudden Unexpected Death in Epilepsy). Individuals with drug-resistant epilepsy need to KNOW THE RISKS of living with seizures AND GET THE FACTS about options beyond medication. We join the epilepsy community today to urge those suffering with seizures to TAKE CONTROL. Talk to an epileptologist about available options and learn more at https://lnkd.in/gD3dQqB2. #OurRisksOurRights
-
-
As the LEADER in #LITT, we are especially honored to be attending The American Academy of Neurological Surgery annual meeting, October 16-19 in Half Moon Bay, California. Discover the latest in laser probe technology, our new NB3 1.6mm cooled probe. Rx Only. https://bit.ly/3pdAg6x
-